Typical breakthrough cancer pain episodes strike many times a day, peak within minutes and last for about a half hour. Nycomed is developing a new way to help patients gain better control over these episodes and lessen their pain and agony.
In order to promote their intranasal analgesic delivery system designed to closely match typical breakthrough cancer pain episodes, Nycomed collaborated with Sentrix Global Health Communication on a series of ads that illustrate the agony people endure when they suffer from these breakthrough cancer pain attacks.
7,552 clicks in 278 w
More Stats +/-